May 9, 2018 / 9:59 AM / 19 days ago

BRIEF-India's Jubilant Life Sciences March-Qtr Consol Net Profit Up 3.2 Pct

May 9 (Reuters) - Jubilant Life Sciences Ltd:

* MARCH QUARTER CONSOL NET PROFIT 1.55 BILLION RUPEES VERSUS PROFIT OF 1.50 BILLION RUPEES LAST YEAR

* MARCH QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 22.52 BILLION RUPEES VERSUS 16.41 BILLION RUPEES LAST YEAR

* RECOMMENDED DIVIDEND OF 3 RUPEES PER SHARE

* SAYS CO PLANS TO INVEST ABOUT 5.50 BILLION RUPEES IN CAPITAL EXPENDITURE IN FY 2019

* PLANS TO INVEST 3 BILLION RUPEES IN RESEARCH AND DEVELOPMENT IN YEAR, INCLUDING 1.50 BILLION RUPEES IN PRODUCT DEVELOPMENT EXPENDITURE

* SAYS H2 FY19 EXPECTED TO BE BETTER THAN H1 FY19 Source text: bit.ly/2K4f0sa Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below